MYELOPROLIFERATIVE NEOPLASM(MPN)-ASSOCIATED MYELOFIBROSIS
Clinical trials for MYELOPROLIFERATIVE NEOPLASM(MPN)-ASSOCIATED MYELOFIBROSIS explained in plain language.
Never miss a new study
Get alerted when new MYELOPROLIFERATIVE NEOPLASM(MPN)-ASSOCIATED MYELOFIBROSIS trials appear
Sign up with your email to follow new studies for MYELOPROLIFERATIVE NEOPLASM(MPN)-ASSOCIATED MYELOFIBROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Blood disorder drug luspatercept gets Long-Term safety review
Disease control Recruiting nowThis study follows about 665 people with myelodysplastic syndromes, beta-thalassemia, or myelofibrosis who have already taken luspatercept in earlier trials. Researchers want to see how safe the drug is over many years by tracking side effects, disease progression, and survival. …
Matched conditions: MYELOPROLIFERATIVE NEOPLASM(MPN)-ASSOCIATED MYELOFIBROSIS
Phase: PHASE3 • Sponsor: Celgene • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Massive new study aims to unlock secrets of rare blood cancers
Knowledge-focused Recruiting nowThis long-term observational study is enrolling 5,000 adults with myeloproliferative neoplasms (MPNs)—rare blood cancers like polycythemia vera and myelofibrosis. Researchers will collect health records, patient surveys, and insurance data over at least five years to track sympto…
Matched conditions: MYELOPROLIFERATIVE NEOPLASM(MPN)-ASSOCIATED MYELOFIBROSIS
Sponsor: MPN Research Foundation • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC